Literature DB >> 12401547

Chrysamine G and its derivative reduce amyloid beta-induced neurotoxicity in mice.

Kazuhiro Ishii1, William E Klunk, Shigeki Arawaka, Manik L Debnath, Yoshiko Furiya, Naruhiko Sahara, Shin'ichi Shoji, Akira Tamaoka, Jay W Pettegrew, Hiroshi Mori.   

Abstract

The neurotoxicity of amyloid beta (Abeta) is widely believed to play a seminal role in neurodegeneration in Alzheimer's disease. We examined the effect of Chrysamine G (CG) on such neurotoxicity using the specific measurement of surviving neurons. CG was found to reduce the neurodegeneration induced by both the active short fragment of Abeta(25-35) and full-sized Abeta(1-40). In this study, we synthesized a new chemical compound from a monovalent structure of CG (hCG), with a lower affinity for Abeta, and compared its activity with that of CG. Both CG and hCG were found to be equally efficacious in reducing Abeta-induced neuronal death at a concentration of 0.1-1 microM, indicating that the mechanism of action for CG was not due to its chelating activity, but rather due to its anti-oxidant activity. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401547     DOI: 10.1016/s0304-3940(02)00915-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Whatever happened to Pittsburgh Compound-A?

Authors:  William E Klunk; Chester A Mathis
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

Review 2.  Development of positron emission tomography β-amyloid plaque imaging agents.

Authors:  Chester A Mathis; N Scott Mason; Brian J Lopresti; William E Klunk
Journal:  Semin Nucl Med       Date:  2012-11       Impact factor: 4.446

3.  Investigation of the effect of erythrosine B on amyloid beta peptide using molecular modeling.

Authors:  Juho Lee; Inchan Kwon; Seung Soon Jang; Art E Cho
Journal:  J Mol Model       Date:  2016-03-28       Impact factor: 1.810

Review 4.  The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease.

Authors:  Solomon Habtemariam
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.